ACADIA Pharmaceuticals Claimed Company
ACADIA Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders. read more
HR or Marketing? Claim Your Free Employer Account
Fred W. Manak Jr. ā Senior Vice President of Access, Reimbursement & Commercial Planning at ACADIA Pharmaceuticals
Executive Bio
Mr. Fred W. Manak, Jr., has been Senior Vice President of Access, Reimbursement & Commercial Planning at ACADIA Pharmaceuticals Inc. since February 12, 2017. Mr. Manak served as Vice President of Access and Reimbursement at ACADIA Pharmaceuticals Inc. from August 2015 to February 12, 2017. Mr. Manak responsible for establishing ACADIA's access and reimbursement strategy to support the planned commercialization of NUPLAZID and other future product opportunities. In addition, Mr. Manak is responsible for managing the ACADIA's government affairs efforts. Mr. Manak has over 25 years of industry experience, primarily in pharmaceutical access, reimbursement, pricing and contracting. He served as Vice President, Market Access at InterMune, Inc. where he led the market access strategy for the launch of Esbriet?? in idiopathic pulmonary fibrosis. Prior to joining InterMune, he served as Vice President, Reimbursement, Access and Value at Onyx Pharmaceuticals, Inc., and as Executive Director, Trade, Pricing and Contract Management at Amgen, Inc. Mr. Manak received his Bachelor of Science in Chemistry from Muhlenberg College.
Executive Team Culture Ratings from ACADIA Pharmaceuticals Employees
BOTTOM
35%
ACADIA Pharmaceuticals' Executive Team scores in the Bottom 35%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at ACADIA PharmaceuticalsNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at ACADIA PharmaceuticalsACADIA Pharmaceuticals' Executive Team at a Glance
Based on 9 ratings, ACADIA Pharmaceuticals' employees are less satisfied with their Executive Team and give them a āC-ā or 65/100.
ACADIA Pharmaceuticals' Executive Team ranks in the Bottom 45% of other companies in San Diego and Bottom 35% of other companies on Comparably that also have 51-200 Employees.
×